Westpac Banking Corp’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $249K | Sell |
3,969
-1,783
| -31% | -$124K | 0.02% | 336 |
|
|
2025
Q4 | $382K | Buy |
5,752
+1,783
| +45% | +$115K | 0.02% | 289 |
|
|
2025
Q3 | $267K | Hold |
3,969
| – | – | 0.02% | 312 |
|
|
2025
Q2 | $346K | Hold |
3,969
| – | – | 0.02% | 293 |
|
|
2025
Q1 | $271K | Sell |
3,969
-901
| -19% | -$73.5K | 0.02% | 302 |
|
|
2024
Q4 | $379K | Buy |
4,870
+680
| +16% | +$50.3K | 0.03% | 301 |
|
|
2024
Q3 | $281K | Buy |
4,190
+675
| +19% | +$55.4K | 0.02% | 337 |
|
|
2024
Q2 | $399K | Hold |
3,515
| – | – | 0.03% | 262 |
|
|
2024
Q1 | $488K | Sell |
3,515
-15,310
| -81% | -$1.92M | 0.04% | 257 |
|
|
2023
Q4 | $2.34M | Buy |
18,825
+15,803
| +523% | +$1.61M | 0.19% | 135 |
|
|
2023
Q3 | $282K | Sell |
3,022
-5,248
| -63% | -$592K | 0.02% | 357 |
|
|
2023
Q2 | $1.06M | Sell |
8,270
-37,204
| -82% | -$4.5M | 0.08% | 254 |
|
|
2023
Q1 | $5.28M | Sell |
45,474
-6,757
| -13% | -$756K | 0.07% | 335 |
|
|
2022
Q4 | $5.91M | Buy |
52,231
+20,459
| +64% | +$2.25M | 0.09% | 291 |
|
|
2022
Q3 | $2.56M | Hold |
31,772
| – | – | 0.04% | 462 |
|
|
2022
Q2 | $2.37M | Buy |
31,772
+260
| +0.8% | +$23.7K | 0.03% | 504 |
|
|
2022
Q1 | $4.03M | Sell |
31,512
-176
| -0.6% | -$19.3K | 0.05% | 421 |
|
|
2021
Q4 | $4.25M | Buy |
31,688
+1,708
| +6% | +$245K | 0.04% | 430 |
|
|
2021
Q3 | $4.1M | Hold |
29,980
| – | – | 0.04% | 450 |
|
|
2021
Q2 | $3.2M | Hold |
29,980
| – | – | 0.03% | 517 |
|
|
2021
Q1 | $2.69M | Sell |
29,980
-42,152
| -58% | -$3.96M | 0.03% | 506 |
|
|
2020
Q4 | $6.67M | Sell |
72,132
-2,000
| -3% | -$179K | 0.08% | 334 |
|
|
2020
Q3 | $7.64M | Sell |
74,132
-34,552
| -32% | -$3.61M | 0.1% | 262 |
|
|
2020
Q2 | $11M | Sell |
108,684
-164,988
| -60% | -$14.8M | 0.16% | 158 |
|
|
2020
Q1 | $18.4M | Buy |
273,672
+75,092
| +38% | +$4.67M | 0.32% | 82 |
|
|
2019
Q4 | $10.9M | Buy |
198,580
+35,600
| +22% | +$1.69M | 0.14% | 199 |
|
|
2019
Q3 | $6.08M | Sell |
162,980
-58,800
| -27% | -$2.28M | 0.08% | 323 |
|
|
2019
Q2 | $8.31M | Buy |
221,780
+40,600
| +22% | +$1.28M | 0.13% | 223 |
|
|
2019
Q1 | $5.39M | Sell |
181,180
-18,600
| -9% | -$654K | 0.09% | 287 |
|
|
2018
Q4 | $5.98M | Buy |
199,780
+31,980
| +19% | +$1.01M | 0.1% | 276 |
|
|
2018
Q3 | $6M | Buy |
+167,800
| New | +$5.2M | 0.1% | 277 |
|
|
2017
Q4 | – | Sell |
-30,616
| Closed | -$374K | – | 728 |
|
|
2017
Q3 | $374K | Hold |
30,616
| – | – | 0.01% | 732 |
|
|
2017
Q2 | $560K | Hold |
30,616
| – | – | 0.01% | 682 |
|
|
2017
Q1 | $649K | Hold |
30,616
| – | – | 0.01% | 732 |
|
|
2016
Q4 | $612K | Buy |
+30,616
| New | +$542K | 0.01% | 664 |
|
Other funds holding DXCM
VCM
VPM
Westpac Banking Corp's DXCM Position: Q1 2026 in Review
Westpac Banking Corp reduced its DexCom (DXCM) stake by 31% in Q1 2026, selling an estimated $124K and leaving 3,969 shares worth $249K. The position accounts for 0.02% of the portfolio, ranked #336.
Westpac Banking Corp first reported a position in DXCM in Q4 2016 and has held it in 35 quarters since. The position peaked at $18.4M in Q1 2020. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Westpac Banking Corp held 3,969 shares of DexCom worth $249K as of Q1 2026.
- Westpac Banking Corp sold 1,783 DexCom shares in Q1 2026, an estimated $124K.
- DexCom made up 0.02% of Westpac Banking Corp's portfolio in Q1 2026, its #336 holding.
- Westpac Banking Corp first reported a position in DexCom in Q4 2016 and has held it in 35 quarters since.
- Westpac Banking Corp's DexCom position peaked at $18.4M in Q1 2020.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Westpac Banking Corp's 13F filing for Q1 2026, filed 12 May 2026.